Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 3
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP25F055C | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $825.78K | 2025-08-12 | 2025-08-26 | 325412 | 8511565494!ADENOVIRUS TYPE 4 A |
| SPE2DP25F9620 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $825.78K | 2025-07-14 | 2025-07-29 | 325412 | 8511499274!ADENOVIRUS TYPE 4 A |
| SPE2DP25F9617 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $825.78K | 2025-07-14 | 2025-07-29 | 325412 | 8511499119!ADENOVIRUS TYPE 4 A |
| SPE2DP25F9616 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $825.78K | 2025-07-14 | 2025-07-29 | 325412 | 8511499116!ADENOVIRUS TYPE 4 A |
| SPE2DP25F8215 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $825.78K | 2025-06-16 | 2025-06-24 | 325412 | 8511446666!ADENOVIRUS TYPE 4 A |
| SPE2DP25F6735 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $825.78K | 2025-05-12 | 2025-05-20 | 325412 | 8511369390!ADENOVIRUS TYPE 4 A |
| SPE2DP25F5526 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $825.78K | 2025-04-07 | 2025-04-29 | 325412 | 8511296206!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1004 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $814.48K | 2020-12-07 | 2020-12-15 | 325412 | 8507846271!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1003 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $814.48K | 2020-12-07 | 2020-12-15 | 325412 | 8507846179!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1002 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $814.48K | 2020-12-07 | 2020-12-15 | 325412 | 8507846177!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6217 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $814.48K | 2020-07-22 | 2020-07-28 | 325412 | 8507538040!ADENOVIRUS TYPE 4 A |
| SPE2DP23F5007 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $763.48K | 2023-07-18 | 2023-07-25 | 325412 | 8510016824!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3964 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $763.48K | 2023-05-17 | 2023-05-23 | 325412 | 8509896001!ADENOVIRUS TYPE 4 A |
| SPE2DP23F1519 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $763.48K | 2023-01-18 | 2023-01-24 | 325412 | 8509643040!ADENOVIRUS TYPE 4 A |
| SPE2DP23F0885 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-12-06 | 2022-12-20 | 325412 | 8509567889!ADENOVIRUS TYPE 4 A |
| SPE2DP22F7353 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-09-13 | 2022-09-20 | 325412 | 8509383419!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6748 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-08-18 | 2022-08-30 | 325412 | 8509324195!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6110 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-07-18 | 2022-07-26 | 325412 | 8509243201!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5147 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-06-14 | 2022-06-28 | 325412 | 8509164430!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4648 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-05-17 | 2022-05-24 | 325412 | 8509104948!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4071 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-04-19 | 2022-04-26 | 325412 | 8509034489!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3537 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $734.12K | 2022-03-22 | 2022-03-29 | 325412 | 8508961298!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4298 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $705.88K | 2021-06-08 | 2021-06-22 | 325412 | 8508275809!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2621 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $705.88K | 2021-03-10 | 2021-03-23 | 325412 | 8508044760!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2056 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $705.88K | 2021-02-11 | 2021-02-23 | 325412 | 8507981433!ADENOVIRUS TYPE 4 A |